Depression
News
Antipsychotic tied to dose-related weight gain, higher cholesterol
Risperidone is an antipsychotic with a “medium to high metabolic risk profile.”
News
Refugees have a high burden of chronic pain associated with mental illness
Elevated rates of PTSD, depression, and anxiety have been repeatedly found in refugee populations and high levels of pain have also been...
Conference Coverage
Long COVID neuropsychiatric deficits greater than expected
Studies document the cognitive and psychiatric effects of long COVID.
Conference Coverage
Antipsychotic safe, effective for resistant depression in phase 3 trial
Previous research has shown almost half of patients with MDD do not experience satisfactory results from their current treatment regimen.
Conference Coverage
Depressed patients respond faster to IV ketamine than intranasal ketamine
One of the first comparator studies shows responses with fewer treatments for depression with IV versus intranasal ketamine.
Conference Coverage
Anxiety in America: COVID ‘takes a backseat’ to global events
Nearly three-quarters (73%) of U.S. adults are somewhat or extremely anxious about current events happening around the world.
News
Does suicide risk show up in the blood?
“This is the first study to analyze blood and brain samples in a well-defined population of MDDs demonstrating significant differences in gene...
Opinion
When burnout is moral injury
Occupational dissatisfaction increases the risk of cynicism, frustration with patients, internalization of failure, and the likelihood of early...
News
New data support electroconvulsive therapy for severe depression
In today’s practice, ECT leads to fewer cognitive side effects than previous treatments.
News
U.S. docs at double the risk of postpartum depression
The high postpartum depression rates among physicians might be associated with worse patient care, said Dr. Alison Stuebe.